Details for New Drug Application (NDA): 077890
✉ Email this page to a colleague
NDA 077890 describes AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, which is a drug marketed by Amneal, Aurobindo Pharma Ltd, Chartwell Rx, Dr Reddys Labs Inc, Heritage, Lupin Pharms, Pharmobedient, Rising, Teva Pharms, Watson Labs, and Watson Labs Inc, and is included in twelve NDAs. It is available from fifteen suppliers. Additional details are available on the AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE profile page.
The generic ingredient in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.
The generic ingredient in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.
Summary for 077890
| Tradename: | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE |
| Applicant: | Watson Labs |
| Ingredient: | amlodipine besylate; benazepril hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 2.5MG BASE;10MG | ||||
| Approval Date: | Oct 14, 2010 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 5MG BASE;10MG | ||||
| Approval Date: | Oct 14, 2010 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 5MG BASE;20MG | ||||
| Approval Date: | Oct 14, 2010 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
